{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:22Z","timestamp":1790787502957,"version":"4.1.0"},"reference-count":106,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>In 1947, Zika virus (ZIKV), a mosquito-borne flavivirus was identified in Uganda and subsequently spread to Asia and the Pacific regions. In 2015, it was introduced in Brazil causing an important social and sanitary alarm due to its increased virulence and rapid dissemination. Importantly, ZIKV infections have been associated with severe neurological complications such as Guillain\u2013Barr\u00e9 syndrome and microcephaly in fetuses and newborns. Although enormous efforts were made by investigators in the development of effective countermeasures against ZIKV, there is still no approved specific antiviral drug for the treatment of ZIKV infections. Herein, we review several anti ZIKV candidates including drugs targeting both the virus (structural proteins and enzymes) and cellular elements.<\/jats:p>","DOI":"10.3390\/ph12030101","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T03:23:59Z","timestamp":1561951439000},"page":"101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Antiviral Agents in Development for Zika Virus Infections"],"prefix":"10.3390","volume":"12","author":[{"given":"Mariana","family":"Baz","sequence":"first","affiliation":[{"name":"Research Center in Infectious Diseases of the CHU of Qu\u00e9bec and Universit\u00e9 Laval, Qu\u00e9bec City, QC G1V 4G2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[{"name":"Research Center in Infectious Diseases of the CHU of Qu\u00e9bec and Universit\u00e9 Laval, Qu\u00e9bec City, QC G1V 4G2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus Flavivirus","volume":"72","author":"Kuno","year":"1998","journal-title":"J. Virol."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (CDC) (2009). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. Morb. Mortal. Wkly. Rep., 58, 969\u2013972."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus. II. Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_4","first-page":"57","article-title":"Twelve Isolations of Zika Virus from Aedes (Stegomyia) Africanus (Theobald) Taken in and above a Uganda Forest","volume":"31","author":"Haddow","year":"1964","journal-title":"Bull. World Health Org."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika Virus Infection in Man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1590\/0074-02760150192","article-title":"First report of autochthonous transmission of Zika virus in Brazil","volume":"110","author":"Zanluca","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hamelin, M.E., Baz, M., Abed, Y., Couture, C., Joubert, P., Beaulieu, E., Bellerose, N., Plante, M., Mallett, C., and Schumer, G. (2010). Oseltamivir-resistant pandemic A\/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001015"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika Virus and Birth Defects\u2014Reviewing the Evidence for Causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Diagne, C.T., Diallo, D., Faye, O., Ba, Y., Faye, O., Gaye, A., Dia, I., Faye, O., Weaver, S.C., and Sall, A.A. (2015). Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1231-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika Virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3201\/eid2101.140894","article-title":"Detection of Zika virus in urine","volume":"21","author":"Gourinat","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Coffey, L.L., Pesavento, P.A., Keesler, R.I., Singapuri, A., Watanabe, J., Watanabe, R., Yee, J., Bliss-Moreau, E., Cruzen, C., and Christe, K.L. (2017). Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus Macaques. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171148"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.chom.2017.01.004","article-title":"Zika Virus Pathogenesis and Tissue Tropism","volume":"21","author":"Miner","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature20556","article-title":"Zika virus infection damages the testes in mice","volume":"540","author":"Govero","year":"2016","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hirsch, A.J., Smith, J.L., Haese, N.N., Broeckel, R.M., Parkins, C.J., Kreklywich, C., DeFilippis, V.R., Denton, M., Smith, P.P., and Messer, W.B. (2017). Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006219"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Besnard, M., Lastere, S., Teissier, A., Cao-Lormeau, V., and Musso, D. (2014). Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Eurosurveillance, 19.","DOI":"10.2807\/1560-7917.ES2014.19.13.20751"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10900-016-0177-7","article-title":"The Convergence of a Virus, Mosquitoes, and Human Travel in Globalizing the Zika Epidemic","volume":"41","author":"Imperato","year":"2016","journal-title":"J. Commun. Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3201\/eid1705.101939","article-title":"Probable non-vector-borne transmission of Zika virus, Colorado, USA","volume":"17","author":"Foy","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(16)00624-3","article-title":"Infectious Zika viral particles in breastmilk","volume":"387","author":"Biron","year":"2016","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","article-title":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: A case study","volume":"16","author":"Calvet","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Musso, D., Nhan, T., Robin, E., Roche, C., Bierlaire, D., Zisou, K., Shan Yan, A., Cao-Lormeau, V.M., and Broult, J. (2014). Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Eurosurveillance, 19.","DOI":"10.2807\/1560-7917.ES2014.19.14.20761"},{"key":"ref_23","first-page":"95","article-title":"Zika virus and the never-ending story of emerging pathogens and transfusion medicine","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Transfus."},{"key":"ref_24","unstructured":"BioCryst Pharmaceuticals Inc. (2011, November 02). BioCryst\u2019s Partner Shinogi Receives Approval for Pediatric Use of Peramivir in Japan. Available online: http:\/\/investor.shareholder.com\/biocryst\/releasedetail.cfm?releaseid=523371."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1099\/0022-1317-72-4-851","article-title":"In vitro synthesis of West Nile virus proteins indicates that the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basic amino acids","volume":"72","author":"Wengler","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01702653","article-title":"Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities","volume":"9","author":"Takegami","year":"1995","journal-title":"Virus Genes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/viro.2002.1504","article-title":"Expression, purification, and characterization of the RNA 5\u2019-triphosphatase activity of dengue virus type 2 nonstructural protein 3","volume":"299","author":"Bartelma","year":"2002","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(00)00270-6","article-title":"Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin","volume":"92","author":"Guyatt","year":"2001","journal-title":"J. Virol. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/JVI.02424-12","article-title":"Membrane topology and function of dengue virus NS2A protein","volume":"87","author":"Xie","year":"2013","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1996.0307","article-title":"Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication","volume":"220","author":"Mackenzie","year":"1996","journal-title":"Virology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika Virus Infection in Human Skin Cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12985-016-0551-1","article-title":"Nucleotide composition of the Zika virus RNA genome and its codon usage","volume":"13","author":"Berkhout","year":"2016","journal-title":"Virol. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Batista, M.N., Braga, A.C.S., Campos, G.R.F., Souza, M.M., Matos, R.P.A., Lopes, T.Z., Candido, N.M., Lima, M.L.D., Machado, F.C., and Andrade, S.T.Q. (2019). Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus. Viruses, 11.","DOI":"10.3390\/v11010049"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Haddad, J.G., Koishi, A.C., Gaudry, A., Nunes Duarte Dos Santos, C., Viranaicken, W., Despres, P., and El Kalamouni, C. (2019). Doratoxylon apetalum, an Indigenous Medicinal Plant from Mascarene Islands, Is a Potent Inhibitor of Zika and Dengue Virus Infection in Human Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102382"},{"key":"ref_42","unstructured":"Tychan Pte Ltd. (2019, May 30). Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients. ClinicalTrials.gov. NCT number: NCT03776695. 2018 Dec. NCT03776695, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03776695."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/22221751.2019.1614885","article-title":"Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model","volume":"8","author":"Niu","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"De Clercq, E., and Neyts, J. (2009). Antiviral agents acting as DNA or RNA chain terminators. Handb. Exp. Pharmacol., 53\u201384.","DOI":"10.1007\/978-3-540-79086-0_3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside Inhibitors of Zika Virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.11.020","article-title":"Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase","volume":"137","author":"Hercik","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zmurko, J., Marques, R.E., Schols, D., Verbeken, E., Kaptein, S.J., and Neyts, J. (2016). The Viral Polymerase Inhibitor 7-Deaza-2\u2019-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004695"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Arnold, J.J., Sharma, S.D., Feng, J.Y., Ray, A.S., Smidansky, E.D., Kireeva, M.L., Cho, A., Perry, J., Vela, J.E., and Park, Y. (2012). Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003030"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3851\/IMP3180","article-title":"In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin","volume":"22","author":"Baz","year":"2017","journal-title":"Antivir. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00705-017-3436-8","article-title":"Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication","volume":"162","author":"Cai","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3389\/fmicb.2017.01469","article-title":"Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives","volume":"8","author":"Munjal","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2016.12.011","article-title":"Sofosbuvir: An antiviral drug with potential efficacy against Zika infection","volume":"55","author":"Reznik","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Govero","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_59","first-page":"323","article-title":"Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold","volume":"392","author":"Perales","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A Mouse Model of Zika Virus Pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.dld.2014.09.026","article-title":"Overall efficacy and safety results of sofosbuvir-based therapies in phase II and III studies","volume":"46","author":"Mangia","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","article-title":"Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses","volume":"142","author":"Eyer","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1021\/jacs.6b10399","article-title":"Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7164\/antibiotics.26.463","article-title":"A9145, a new adenine-containing antifungal antibiotic. I. Discovery and isolation","volume":"26","author":"Hamil","year":"1973","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acschembio.5b00812","article-title":"SAM\/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases","volume":"11","author":"Zhang","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00705-017-3345-x","article-title":"Structural basis of Zika virus methyltransferase inhibition by sinefungin","volume":"162","author":"Hercik","year":"2017","journal-title":"Arch. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Hart, D.T. (1989). Potential Clinical Use of Sinefungin: Reduction of Toxicity and Enhancement of Activity. Leishmaniasis, Springer.","DOI":"10.1007\/978-1-4613-1575-9"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/14787210.2016.1120670","article-title":"The preventive and therapeutic potential of natural polyphenols on influenza","volume":"14","author":"Bahramsoltani","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3389\/fmicb.2017.01314","article-title":"Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus","volume":"8","author":"Saiz","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3748\/wjg.v22.i1.188","article-title":"Naturally derived anti-hepatitis B virus agents and their mechanism of action","volume":"22","author":"Wu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10529-016-2261-6","article-title":"Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship","volume":"39","author":"Lim","year":"2017","journal-title":"Biotechnol. Lett."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Roy, A., Lim, L., Srivastava, S., Lu, Y., and Song, J. (2017). Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180632"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1999.9723","article-title":"The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells","volume":"258","author":"Aguilar","year":"1999","journal-title":"Virology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-3542(93)90022-B","article-title":"Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives","volume":"20","author":"Baba","year":"1993","journal-title":"Antivir. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/AAC.03595-14","article-title":"Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin","volume":"58","author":"Ellenbecker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.12.008","article-title":"Suramin inhibits EV71 infection","volume":"103","author":"Wang","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","article-title":"Suramin treatment reduces chikungunya pathogenesis in mice","volume":"134","author":"Kuo","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/emi.2014.60","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo","volume":"3","author":"Ren","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","article-title":"Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens","volume":"149","author":"Tong","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.12688\/f1000research.9648.1","article-title":"Zika antiviral chemotherapy: Identification of drugs and promising starting points for drug discovery from an FDA-approved library","volume":"5","author":"Pascoalino","year":"2016","journal-title":"F1000Research"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti-HCV profiles of statins and their potential for combination therapy with interferon","volume":"44","author":"Ikeda","year":"2006","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol biosynthesis modulation regulates dengue viral replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","article-title":"Lovastatin attenuates nerve injury in an animal model of Guillain-Barre syndrome","volume":"100","author":"Sarkey","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am. J. Obstet Gynecol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","volume":"5","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-999371","article-title":"Pregnancy outcome following first trimester exposure to chloroquine","volume":"8","author":"Levy","year":"1991","journal-title":"Am. J. Perinatol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Delvecchio, R., Higa, L.M., Pezzuto, P., Valadao, A.L., Garcez, P.P., Monteiro, F.L., Loiola, E.C., Dias, A.A., Silva, F.J., and Aliota, M.T. (2016). Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models. Viruses, 8.","DOI":"10.1101\/051268"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2016.12.022","article-title":"Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism","volume":"139","author":"Kuivanen","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., and Greber, U.F. (2012). Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002976"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Costa, V.V., Del Sarto, J.L., Rocha, R.F., Silva, F.R., Doria, J.G., Olmo, I.G., Marques, R.E., Queiroz-Junior, C.M., Foureaux, G., and Araujo, J.M.S. (2017). N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection. mBio, 8.","DOI":"10.1128\/mBio.00350-17"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/12\/3\/101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:30Z","timestamp":1760187750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/12\/3\/101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,29]]},"references-count":106,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ph12030101"],"URL":"https:\/\/doi.org\/10.3390\/ph12030101","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,29]]}}}